4 recalls found for Boothwyn Pharmacy. Check if any of your products are affected.
Boothwyn Pharmacy recalled 186 vials of Semaglutide, 2.5 mg/mL injection on July 9, 2025. The product is subpotent and poses a risk to consumers. Healthcare providers and consumers should stop using this product immediately.
Boothwyn Pharmacy recalled 8 vials of Fluorescein 2% Ophthalmic Solution on July 9, 2025. The recall occurred due to the drug being subpotent, posing potential health risks. Consumers should stop using the product immediately and seek guidance from their healthcare provider.
Boothwyn Pharmacy recalled 648 vials of Semaglutide injection on July 9, 2025. The product is subpotent and poses a high hazard risk. Consumers should stop using the product immediately and contact their healthcare provider.
Boothwyn Pharmacy recalled 642 vials of Semaglutide injection on July 9, 2025. The recall follows the discovery that the drug is subpotent. Consumers should stop using the product immediately and seek guidance from healthcare providers.